| Type of procedure | |
|---|---|
| Lung resections | 98 |
| Head & neck surgery | 54 |
|
Bowel, bladder or gynecological resections |
48 |
| Spinal surgery | 28 |
| Hepatic resections | 20 |
| Cholecystectomy | 18 |
| Nephrectomy | 17 |
| Arterial vascular procedures | 13 |
| Neurosurgery | 9 |
| Other thoracic resections | 7 |
| Total | 312 |
Real world clinical evaluations
TenaTac® has been evaluated in over 300 surgical procedures in 18 countries. Surgeons completed a structured assessment form and the results are summarised in the tables below.
In 98% of the evaluations, surgeons recommended TenaTac®
Graph showing surgeon rating of TenaTac® for each of seven attributes tested
TenaTac® has been evaluated in a wide range of surgical procedures:
Preclinical studies
TenaTac® has been evaluated in porcine and leporine models. In multiple liver haemostasis models, the product has demonstrated significantly improved adhesion and haemostatic efficacy compared to the market-leading adhesive patch (Data on file).
The tolerability and absorption of TenaTac® was tested in a GLP/ISO compliant study in a porcine model over 42 days. This study demonstrated good tolerability and absorption within 14 days (Data on file).
TenaTac® demonstrates significantly stronger tissue adhesion than a market leading adhesive patch
